Assessing molecular scaffolds for CNS drug discovery

Article English OPEN
Mayol-Llinas, J; Nelson, A; Farnaby, W; Ayscough, A;
  • Publisher: Elsevier

There is a need for high-quality screening collections that maximise hit rate and minimise the time taken in lead optimisation to derive a candidate drug. Identifying and accessing molecules that meet these criteria is a challenge. Within central nervous system (CNS)-fo... View more
Share - Bookmark